Identification of the Type I Collagen-binding Domain of Bone Sialoprotein and Characterization of the Mechanism of Interaction

• Published in: The Journal of biological chemistry 2005-04, Vol.280 (14), p.13487-13492
• Main Authors: Tye, Coralee E., Hunter, Graeme K., Goldberg, Harvey A.
• Format: Article
• Language: English
• Subjects: Animals; Collagen Type I - genetics; Collagen Type I - metabolism; Hydrogen-Ion Concentration; Integrin-Binding Sialoprotein; Ions - metabolism; Peptides - chemical synthesis; Peptides - genetics; Peptides - isolation & purification; Peptides - metabolism; Protein Binding; Protein Conformation; Protein Processing, Post-Translational; Protein Structure, Tertiary; Rats; Sialoglycoproteins - chemistry; Sialoglycoproteins - genetics; Sialoglycoproteins - metabolism; Static Electricity
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M408923200

Bone sialoprotein (BSP) is an anionic phosphorylated glycoprotein that is expressed almost exclusively in mineralized tissues and has been shown to be a potent nucleator of hydroxyapatite formation. The binding of BSP to collagen is thought to be important for the initiation of bone mineralization and in the adhesion of bone cells to the mineralized matrix. Using a solid phase assay, we have investigated the interaction between BSP and collagen. Initial studies showed that raising the ionic strength, decreasing the pH below 7, or introducing divalent cations diminishes but does not abolish the binding of BSP to collagen, indicating that the interaction is only partly electrostatic in nature. Both bone-extracted and recombinant (r)BSP exhibited similar binding affinities, indicating that post-translational modifications are not critical for binding. To identify the collagen-binding domain, recombinant peptides of BSP were studied. Peptide rBSP-(1–100) binds to type I collagen with an affinity similar to that of full-length rBSP, whereas peptides containing the sequences 99–201 or 200–301 do not bind. Further studies showed that rBSP-(1–75) competitively inhibits the binding of rBSP-(1–100), whereas rBSP-(21–100) inhibits binding to a lesser extent, and rBSP-(43–100) does not inhibit binding. These results suggest that the collagen-binding site of rat BSP is within the sequence 21–42, with residues N-terminal of this region likely also involved. This site was confirmed by the demonstration of collagen-binding activity of a synthetic peptide corresponding to residues 19–46. The collagen-binding domain, which is highly conserved among species, is enriched in hydrophobic residues and lacks acidic residues. We conclude that residues 19–46 of BSP represent a novel collagen-binding site.